Low-dose chemotherapy also increases the influx of CD8 T cells into the tumor in pre-clinical models of glioblastoma [89], but the peripheral lymphodepletion in patients treated with chemotherapy may counteract these beneficial effects [79]. The gene discussed is CD8A; the disease is glioblastoma.